Loading
Latest filing published 31 May 2016 for Abattis Bioceuticals Corp., €343.
No signal scores available.
Maryam Amin Shanjani appears in our data through filings on Abattis Bioceuticals Corp. shares, published by SEDI. Over a trading history stretching from 19 May 2016 to 31 May 2016, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €343 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 31 May 2016 came the latest disclosure, an open-market purchase for €343 in Abattis Bioceuticals Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations